Aveanna Healthcare Holdings Announces Second Quarter Financial Results and Revised 2026 Guidance
Aveanna reported Q2 revenue of $670.5 million, up 13.7% year-over-year, driven by organic growth across its three business segments. Net income increased to $40.3 million, or $0.18 per diluted share, while Adjusted EBITDA rose 8.0% to $95.4 million.
Key figures
- Eps
- 0.18
- Revenue
- 670500000
- Guidance
- FY26 Revenue >$2.68B (raised from $2.63B-$2.65B); Adjusted EBITDA >$365M (raised from $338M-$342M)
- Revenue Yoy
- 13.7%
- Net income
- 40300000
- Gross margin
- 32.6%
- Free cash flow
- 75400000
- Adjusted ebitda
- 95400000
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.